Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders

Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders

US Patent 9238677 · Granted Jan 19, 2016

Estimated economic value: $9,839,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Ultra-pure agonists of guanylate cyclase C, method of making and using same2024
Dactinomycin compositions and methods for the treatment of myelodysplastic syndr2024
Ultra-pure agonists of guanylate cyclase C, method of making and using same2023
Ultra-pure agonists of guanylate cyclase C, method of making and using same2022
Ultra-pure agonists of guanylate cyclase C, method of making and using same2021
Dactinomycin compositions and methods for the treatment of myelodysplastic syndr2021
Agonists of guanylate cyclase and their uses2021
Agonists of guanylate cyclase and their uses2021
Formulations of milciclib and therapeutic combinations of the same for use in th2020
Ultra-pure agonists of guanylate cyclase C, method of making and using same2020
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disor2020
Agonists of guanylate cyclase useful for the treatment of gastrointestinal disor2020